Biomarkers and Molecular Abnormalities: What Do Patients Need to Know?

Dr. Alison Moliterno (Johns Hopkins University School of Medicine, Baltimore) discusses biomarkers and molecular abnormalities at the 9th International Symposium on Myeloproliferative Neoplasms, New York City, November 1, 2017.